Every active. Honest doses.

The single most-studied botanical for blood-glucose support. Multiple randomised trials (notably Yin 2008) compared 1,500mg/day berberine directly to metformin and found broadly comparable effects on HbA1c, fasting glucose, and lipid markers over 12 weeks. The mechanism is AMPK activation — the same cellular pathway metformin targets.

Cinnamon's water-soluble polyphenols have direct effects on insulin receptor sensitivity and blood-glucose handling after meals. Multiple meta-analyses support modest but consistent reductions in fasting glucose at 1g+/day doses over 8-12 weeks.

An FDA-recognised active for blood glucose maintenance. Chromium is required by the cellular machinery that responds to insulin; deficiency impairs glucose handling. Most middle-aged adults consume below the recommended intake from food alone.

A potent antioxidant with specific evidence for diabetic neuropathy and general glucose-related oxidative stress. Used in Germany since the 1970s as a prescribed adjunct to diabetic care; in over-the-counter doses, it supports the same mechanisms preventively.

A flavonoid with insulin-sensitising and anti-inflammatory effects. Modest evidence in human trials at supplemental doses for fasting glucose and inflammatory markers in pre-diabetic populations.

Magnesium deficiency is independently associated with insulin resistance and pre-diabetes risk. Roughly half of American adults consume below the recommended intake. The glycinate form is well-absorbed and gentle on the stomach.